Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
743 stories · page 2 of 8
FTSE 100 live: Stocks sink after GSK hit by US vaccine ruling, US data points to slowdown
FTSE 100 down 18 points to 8206
Archive
FTSE 100 Live: Stocks fade into the close on fresh US banking nerves
The FTSE 100 closed down 0.5% at 7,630.57
GSK falls victim to ‘hard to please’ pharma market
Modest future earnings per share growth may have deterred investors, Stifel said
Archive
FTSE 100 Live: Stocks close higher ahead of US rate call
The FTSE 100 index closed up 20.71 points, 0.3%, at 7,342.43 while the FTSE 250 ended up 102.84 points, 0.6%, at 17,185.89
Archive
FTSE 100 Live: Stocks close lower after strong US inflation data
At the close, London's lead index was down 8.18 points, 0.1%, at 7,620.03 while the FTSE 250 was down 91.43 points, 0.5%, at 17,876.24
GSK opens new site in UK, unlike rival AstraZeneca
Ware, the site of its life science campus, will house the new plant
FIVE at FIVE: Biden/Modi bromance; Ocadon’t; Siemens’ turbine warning; GSK Zantac settlement; Lloyds under scrutiny
Here’s Proactive’s round-up of the top financial stories of the day, with helpful links taking you directly to the news
FTSE 100 to dip, banks meet with Chancellor over mortgage rates
FTSE 100 to shed 18 at the open fro yesterday's close says spread bet firms
FIVE at FIVE: Darktrace faces down short sellers; Starbucks caf-fiends; Entain raises guidance; GSK beats the street
Here’s Proactive’s round-up of the top financial stories of the day, with helpful links taking you directly to the news
GSK financials should look good but clinic is the focus
Clinical results have been more mixed with Myeloma treatment Blenrep dropped after disappointing trial results